Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Saudi Arabia

Saudi Arabia

Saudi Arabia's Digestives & Intestinal Remedies market market is projected to generate a revenue of US$75.10m in 2024.
This market is anticipated to experience an annual growth rate of 0.80% (CAGR 2024-2029).
When compared to other countries worldwide, in China leads with a revenue of US$4,408.00m in 2024.
Looking at the per capita perspective, in 2024, each individual in Saudi Arabia contributes approximately US$2.00 to the revenue of this market.
In Saudi Arabia, there is a growing demand for natural digestive remedies, as consumers are increasingly seeking holistic approaches to healthcare.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Saudi Arabia is experiencing significant growth and development due to various factors.

Customer preferences: Customers in Saudi Arabia are increasingly seeking natural and herbal remedies for digestive issues. They are becoming more health-conscious and are looking for products that are free from artificial ingredients and chemicals. This shift in preference towards natural remedies has led to an increase in demand for herbal digestive supplements and probiotics in the market. Additionally, customers are also showing a preference for products that are easy to consume and provide quick relief from digestive problems.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Saudi Arabia is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help maintain a healthy balance of gut bacteria and improve digestion. The increasing awareness about the benefits of probiotics has led to a surge in demand for probiotic supplements and yogurts in the market. Customers are recognizing the role of probiotics in improving overall gut health and are incorporating them into their daily routines.Another trend in the market is the rising prevalence of digestive disorders in Saudi Arabia. Factors such as unhealthy diet, sedentary lifestyle, and stress have contributed to an increase in digestive issues among the population. As a result, there is a growing need for digestive remedies to alleviate symptoms such as indigestion, bloating, and acid reflux. This has created a lucrative market for digestive supplements and antacids in the country.

Local special circumstances: Saudi Arabia has a large population of expatriates from different countries, which has influenced the Digestives & Intestinal Remedies market. These expatriates bring with them their own preferences and cultural practices related to digestive health. As a result, there is a diverse range of products available in the market to cater to the specific needs and preferences of different communities. This diversity in product offerings has contributed to the growth of the market and has allowed customers to choose from a wide range of options.

Underlying macroeconomic factors: The growing economy of Saudi Arabia has also played a role in the development of the Digestives & Intestinal Remedies market. As the country's economy continues to expand, disposable incomes are increasing, allowing customers to spend more on healthcare and wellness products. This has led to a rise in demand for digestive remedies as customers prioritize their health and well-being.In conclusion, the Digestives & Intestinal Remedies market in Saudi Arabia is witnessing growth and development due to the preferences of customers for natural remedies, the trends of probiotics and the rising prevalence of digestive disorders. The local special circumstances of a diverse population and the underlying macroeconomic factors of a growing economy have also contributed to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.